AUPH (Aurinia Pharmaceuticals) Utang jangka cendhak marang modal

Logo korporat perusahaan Aurinia Pharmaceuticals (AUPH)

The Aurinia Pharmaceuticals (AUPH) price chart on GURU.Markets reflects the dynamics of a specialized biopharma company whose revenue is based on the sale of an approved lupus nephritis treatment, with the metric standing at 0.03. Peter Greenleaf aims to maximize the product's commercial success by reducing costs. Following unsuccessful attempts to sell the business, Aurinia Pharmaceuticals (AUPH) shifted toward aggressive cost-cutting and independent drug promotion.

Rasio tanggungan utang jangka cendhak marang modal: Aurinia Pharma (AUPH) kanggo 04.07.2022 - 01.11.2026
Produk merek Aurinia Pharmaceuticals Inc

Amid market volatility, capital protection requires strict monitoring of liabilities maturing within one year relative to equity. Since Aurinia Pharmaceuticals (AUPH) has outsourced production to third-party contractors, the short-term leverage ratio is critical for assessing liquidity when settling with vendors, allowing investors to determine the business's dependence on short-term debt financing and the overall resilience of the portfolio.

Pesaing utama

Utang jangka cendhak marang modal ARGX|BNTX (BioNTech Pharma) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal ABVX (Abivax Pharma)|Utang jangka cendhak marang modal admabiologics.com ADMA|PTGX - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Grifols Biemat|ADPT (Adaptive Biotechnologies) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal celldex.com|Rasio utang jangka cendhak marang ekuitas BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal DNTH (Dianthus Pharma)|Koefisien utang jangka cendhak marang modal Pharvaris Pharma (PHVS)|ABCL - Utang jangka cendhak marang ekuitas|tourmalinebio.com (TRML) - Rasio utang jangka cendhak marang ekuitas|Precigen (PGEN) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Pharming Group NV|Rasio utang jangka cendhak marang ekuitas NKTR|Utang jangka cendhak marang modal Upstream Pharma|Utang jangka cendhak marang ekuitas Zenas Biopharma Inc (ZBIO)|immunome.com - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Kewajiban jangka cendhak marang modal|Septerna Corp - Utang jangka cendhak marang modal|PVLA - Utang jangka cendhak marang modal|SVRA (Savara Inc.) - Rasio utang jangka cendhak marang ekuitas|rigel.com (RIGL) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas AnaptysBio|ATXS: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal ENGN|Koefisien utang jangka cendhak marang modal rapt.com|Utang jangka cendhak marang ekuitas Aerovate Therapeutics JBIO|ACRS: Rasio utang jangka cendhak marang modal|Kyverna Therapeutics, Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Tiziana Life Sciences Ltd. TLSA|CABA: Utang jangka cendhak marang modal|Ventyx Biosciences, Inc (VTYX) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas THTX|AVTX: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Eledon Pharmaceuticals, Inc. (ELDN)|AGEN: Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang modal CLYM (Climb Bio, Inc.)|Rasio tanggungan utang jangka cendhak marang modal ZURA|aTyr Pharma, Inc. - Utang jangka cendhak marang modal|ADAG - Utang jangka cendhak marang modal|ikenaoncology.com (IMA) - Utang jangka cendhak marang ekuitas|Shattuck Labs - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Equillium Inc|Rasio utang jangka cendhak marang ekuitas Connect Pharma (CNTB)|Utang jangka cendhak marang modal IMUX|Utang jangka cendhak marang modal atarabio.com (ATRA)|Utang jangka cendhak marang modal IFRX (InflaRx)|XFOR - Rasio utang jangka cendhak marang ekuitas|Adicet - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Celularity Inc.|INMB (INmune Bio, Inc.) - Rasio utang jangka cendhak marang ekuitas|barinthusbio.com (BRNS) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas KZR|SABS (SAB Biotherapeutics Inc.) - Rasio silihan jangka cendhak marang modal|Utang jangka cendhak marang modal AKTX|Koefisien utang jangka cendhak marang modal enlivex.com|Utang jangka cendhak marang modal QTTB (Q32 Bio)|GOVX - Rasio utang jangka cendhak marang ekuitas|Edesa Biotech - Utang jangka cendhak marang modal|IBIO - Utang jangka cendhak marang modal|carismatx.com (CARM) - Utang jangka cendhak marang ekuitas|XTLB (XTL Bio) - Utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Bolt Biotherapeutics Inc.|HCW Biologics Inc (HCWB) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang modal APVO|Utang jangka cendhak marang modal aimimmuno.com (AIM)|Aditxt, Inc. - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal GRI Bio Corporation GRI|XRTX - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas HIND|REVB: Utang jangka cendhak marang modal|Indaptus Therapeutics Inc - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Scinai|CalciMedica Corp - Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang modal AFMD|ALLK (allakos.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal HOOK (HOOKIPA Pharma)|Utang jangka cendhak marang modal IGM Biosciences Inc. IGMS|ITOS - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal OCEA (Ocean Biomedical Corp)|TC Biopharm (TCBP) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas thirdharmonicbio.com